Oncology Research and Treatment

Papers
(The TQCC of Oncology Research and Treatment is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
PharmaNews25
Polypharmazie - Wechselwirkungen der BTKi24
uGI: Biomaker-Cut-Offs in der Immunonkologie23
Front & Back Matter21
Front & Back Matter20
PharmaNews18
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 202318
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience17
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study14
Society Bulletins13
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice13
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient selection and surgical management in advanced ovarian cancer: what tools do we have to make the right decision?13
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis12
Career and Professional Development for Young Oncologists12
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors12
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial11
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease10
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center9
Society Bulletins9
OnkoImmun 217
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem7
Front & Back Matter7
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis7
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 757
PharmaNews7
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy7
Sustained clinical response to Olaparib in a patient with metastatic pancreatic cancer and somatic ATM-Mutation R2034Ter: a case report6
PharmaNews6
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine6
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany6
DKK 2024: Acalabrutinib im Praxis-Check5
Front & Back Matter5
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz5
Evaluating the benefits and challenges of using patient preferences as a tool for clinical decision making in oncology MDT meetings within the National Health Service (NHS): A qualitative study5
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors5
Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer5
PharmaNews4
PharmaNews4
Vorwort des DGHO-Vorstands4
Therapiemanagement von Sacituzumab Govitecan4
Prelims4
Epcoritamab: Indikationserweiterung für das FL4
Society Bulletins4
PharmaNews4
PharmaNews4
Tumor Infiltrating Lymphocytes, CAR-, and T Cell Receptor- Modified T Cells in Solid Cancer Oncology4
Front & Back Matter4
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients4
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial4
NSCLC: RWE-Daten zur Sequenztherapie4
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%3
Perspectives for Cancer Care and Research in Central and Eastern Europe3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer3
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report3
Oncology in Europe3
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein3
Risk and Prognosis of Subsequent Primary Gastric Cancer3
Safety and efficacy of pharmacotherapy containing the second-generation INSTIs and chemotherapy drugs in AIDS-related diffuse large B-cell lymphoma: a single-center retrospective analysis3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie3
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL3
Erratum3
Durvalumab auch bei Hirnmetastasen vorteilhaft3
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac3
Das inoperable NSCLC im Stadium III im Dialog3
Society Bulletins3
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment2
OnkoImmun 192
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review2
PharmaNews2
Recent Advances in Castleman Disease2
Society Bulletins2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study2
Modifications to prostate cancer diagnosis following COVID-19 and following models2
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin2
Society Bulletins2
Society Bulletins2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries using GPT-4o Enhanced with German Evidence-Based Guidelines2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie2
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen2
PharmaNews2
Society Bulletins2
Front & Back Matter2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich2
Management of Patients Undergoing CAR-T Cell Therapy in Germany2
Society Bulletins1
PharmaNews1
PharmaNews1
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis1
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma1
Contents Vol. 47, 20241
Nintedanib und Docetaxel beim Adenokarzinom der Lunge1
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study1
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study1
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy1
OnkoImmun 181
Front & Back Matter1
Society Bulletins1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis1
Front & Back Matter1
Prelims1
Erweiterte Therapieoptionen bei EGFRm NSCLC1
Front & Back Matter1
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis1
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study1
PharmaNews1
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study1
Front & Back Matter1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review1
Prognostic Significance of HER2 Positivity in Endometrium Cancer1
Acknowledgement to Reviewers1
PharmaNews1
Prelims1
Nivolumab plus Ipilimumab beim metastasierten Melanom1
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20231
0.046650886535645